TTIC
AZN icon

Tower Trust & Investment Company’s AstraZeneca AZN Stock Holding History

Tower Trust & Investment Company’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.88K Buy
31
+4
+15% +$752 ﹤0.01% 193
2026
Q1 		$5.32K Sell
27
-1
-4% -$193 ﹤0.01% 186
2025
Q4 		$5.06K Hold
28
– – ﹤0.01% 186
2025
Q3 		$4.22K Hold
28
– – ﹤0.01% 175
2025
Q2 		$3.84K Hold
28
– – ﹤0.01% 181
2025
Q1 		$3.95K Buy
+28
New +$4.05K ﹤0.01% 181

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Tower Trust & Investment Company's AZN Position: Q2 2026 in Review

Tower Trust & Investment Company increased its AstraZeneca (AZN) stake by 15% in Q2 2026, buying an estimated $752 and bringing the position to 31 shares worth $5.88K. The position accounts for ﹤0.01% of the portfolio, ranked #193.

Tower Trust & Investment Company first reported a position in AZN in Q1 2025 and has held it in 6 quarters since. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Tower Trust & Investment Company held 31 shares of AstraZeneca worth $5.88K as of Q2 2026.
  • Tower Trust & Investment Company bought 4 AstraZeneca shares in Q2 2026, an estimated $752.
  • AstraZeneca made up ﹤0.01% of Tower Trust & Investment Company's portfolio in Q2 2026, its #193 holding.
  • Tower Trust & Investment Company first reported a position in AstraZeneca in Q1 2025 and has held it in 6 quarters since.
  • 655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Tower Trust & Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.